# Alzamend Neuro, Inc.: Form SCHEDULE 13D/A, filed Sep 30, 2025

- Company: [Alzamend Neuro, Inc.](/companies/alzn.md) (CIK 1677077)
- Form: SCHEDULE 13D/A
- Filed: 2025-09-30
- Accepted by EDGAR: Sep 30, 2025, 20:51 ET
- Period: not reported
- Accession: 0001214659-25-014424
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1677077/000121465925014424/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1677077/000121465925014424/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1677077/000121465925014424/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Sep 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001214659-25-014424. Last ingested by Listed: Nov 11, 2026, 01:45 ET. No prices; not investment advice.
